|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 1998 studies with search of: | (prostate cancer) [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
|
||||
| 2 | Active, not recruiting |
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
|
||||
| 3 | Active, not recruiting |
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
|
||||
| 4 | Not yet recruiting |
Pharmacodynamic Study of Abiraterone in the Treatment of Advanced Prostate Cancer
|
||||
| 5 | Recruiting |
Monoclonal Antibody to OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
|
||||
| 6 | Not yet recruiting |
Sipuleucel-T Manufacturing Demonstration Study
|
||||
| 7 | Recruiting |
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
|
||||
| 8 | Recruiting |
SOM 230 and Everolimus in Combination for the Treatment of Prostate Cancer
|
||||
| 9 | Completed |
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
|
||||
| 10 | Unknown † |
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
|
||||
| 11 | Completed |
Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer
|
||||
| 12 | Unknown † |
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer and Their First-Degree Relatives
|
||||
| 13 | Active, not recruiting |
PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy
|
||||
| 14 | Recruiting |
A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)
|
||||
| 15 | Active, not recruiting |
The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer
|
||||
| 16 | Unknown † |
Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy
|
||||
| 17 | Recruiting |
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
|
||||
| 18 | Active, not recruiting |
An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer
|
||||
| 19 | Completed |
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
|
||||
| 20 | Recruiting |
MR Image Guided Therapy in Prostate Cancer
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|